Παρακολούθηση
Ourania Tsitsilonis
Ourania Tsitsilonis
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα biol.uoa.gr - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Harnessing the immune system to improve cancer therapy
NE Papaioannou, OV Beniata, P Vitsos, O Tsitsilonis, P Samara
Annals of translational medicine 4 (14), 2016
3032016
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
IP Trougakos, K Stamatelopoulos, E Terpos, OE Tsitsilonis, E Aivalioti, ...
Journal of Biomedical Science 28, 1-18, 2021
2942021
Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
CN Baxevanis, IF Voutsas, OE Tsitsilonis, AD Gritzapis, R Sotiriadou, ...
The Journal of Immunology 164 (7), 3902-3912, 2000
2102000
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
AC Ziogas, NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, E Terpos, ...
International journal of cancer 130 (4), 857-864, 2012
1622012
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
NG Gavalas, M Tsiatas, O Tsitsilonis, E Politi, K Ioannou, AC Ziogas, ...
British journal of cancer 107 (11), 1869-1875, 2012
1522012
Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice
CN Baxevanis, IF Voutsas, OE Tsitsilonis, ML Tsiatas, AD Gritzapis, ...
European journal of immunology 30 (7), 1957-1966, 2000
1232000
Correlation of NK T-like CD3+ CD56+ cells and CD4+ CD25+ (hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum …
A Bamias, V Koutsoukou, E Terpos, ML Tsiatas, C Liakos, O Tsitsilonis, ...
Gynecologic oncology 108 (2), 421-427, 2008
1152008
Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis
F Sesti, OE Tsitsilonis, A Kotsinas, IP Trougakos
In Vivo 26 (3), 395-402, 2012
1082012
Expression of alpha-thymosins in human tissues in normal and abnormal growth.
OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ...
Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993
941993
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with …
A Bamias, ML Tsiatas, E Kafantari, C Liakou, A Rodolakis, Z Voulgaris, ...
Gynecologic oncology 106 (1), 75-81, 2007
932007
HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes
CN Baxevanis, AD Gritzapis, OE Tsitsilonis, HL Katsoulas, M Papamichail
International journal of cancer 98 (6), 864-872, 2002
592002
Toll-like receptor agonists: current status and future perspective on their utility as adjuvants in improving antic ancer vaccination strategies
CN Baxevanis, IF Voutsas, OE Tsitsilonis
Immunotherapy 5 (5), 497-511, 2013
582013
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
K Ioannou, P Samara, E Livaniou, E Derhovanessian, OE Tsitsilonis
Cancer Immunology, Immunotherapy 61, 599-614, 2012
552012
Polar Constituents of Marrubium thessalum Boiss. & Heldr. (Lamiaceae) and their Cytotoxic/Cytostatic Activity
A Argyropoulou, P Samara, O Tsitsilonis, H Skaltsa
Phytotherapy Research 26 (12), 1800-1806, 2012
532012
Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
E Kastritis, IV Kostopoulos, E Terpos, B Paiva, D Fotiou, M Gavriatopoulou, ...
Blood cancer journal 8 (5), 46, 2018
492018
Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha
P Klimentzou, M Paravatou-Petsotas, C Zikos, A Beck, M Skopeliti, ...
Peptides 27 (1), 183-193, 2006
492006
Cytotoxicity and immunomodulating characteristics of labdane diterpenes from Marrubium cylleneum and Marrubium velutinum
A Karioti, M Skopeliti, O Tsitsilonis, J Heilmann, H Skaltsa
Phytochemistry 68 (11), 1587-1594, 2007
472007
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights
C Cheimonidi, P Samara, P Polychronopoulos, EN Tsakiri, T Nikou, ...
Redox Biology 16, 169-178, 2018
462018
Prothymosin α immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a β-sheet conformation in a …
M Skopeliti, VA Iconomidou, E Derhovanessian, G Pawelec, W Voelter, ...
Molecular immunology 46 (5), 784-792, 2009
462009
Proteomic exploitation on prothymosin α‐induced mononuclear cell activation
M Skopeliti, U Kratzer, F Altenberend, G Panayotou, H Kalbacher, ...
Proteomics 7 (11), 1814-1824, 2007
452007
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20